NLGN1 and familial pancreatic carcinoma: The expression pattern in the prostate suggests that the expression of this protein is present during the mildly aggressive phases of progression, and falls at higher stages, which is in agreement with the low expression of NLGN1 in pancreatic cancer at all stages that we analyzed.